GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Balaxi Pharmaceuticals Ltd (NSE:BALAXI) » Definitions » Ending Cash Position

Balaxi Pharmaceuticals (NSE:BALAXI) Ending Cash Position : ₹0 Mil (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Balaxi Pharmaceuticals Ending Cash Position?

Balaxi Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2023 was ₹0 Mil.

Balaxi Pharmaceuticals's annual Ending Cash Position increased from Mar. 2021 (₹17 Mil) to Mar. 2022 (₹72 Mil) and increased from Mar. 2022 (₹72 Mil) to Mar. 2023 (₹282 Mil).

Balaxi Pharmaceuticals Ending Cash Position Historical Data

The historical data trend for Balaxi Pharmaceuticals's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Balaxi Pharmaceuticals Ending Cash Position Chart

Balaxi Pharmaceuticals Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only 1.03 39.80 16.57 71.90 282.12

Balaxi Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Balaxi Pharmaceuticals Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Balaxi Pharmaceuticals's Ending Cash Position for the fiscal year that ended in Mar. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=71.899+210.221
=282

Balaxi Pharmaceuticals's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0+0
=0

Balaxi Pharmaceuticals Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Balaxi Pharmaceuticals's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Balaxi Pharmaceuticals (NSE:BALAXI) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Balaxi Pharmaceuticals Ltd (NSE:BALAXI) » Definitions » Ending Cash Position
Comparable Companies
BOM:500259 BOM:524717 BOM:532890 BOM:540679 BOM:524663 BOM:511509 BOM:526139 BOM:542910 BOM:514336 BOM:539206 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
Phase-III, Road No: 81, Jubilee Hills, Plot No.409, H,No: 8-2-293, MAPS Towers, 2nd Floor, Hyderabad, TG, IND, 500 096
Website
https://www.balaxipharma.in
Balaxi Pharmaceuticals Ltd is an Indian branded IPR-based pharmaceutical company focusing on frontier markets, with a vast and growing portfolio of prescription and OTC drugs, across multiple therapeutic segments. Substantial revenue is generated from the pharmaceutical segment division from generic drugs. Geographically it earns key revenue from Angola.

Balaxi Pharmaceuticals (NSE:BALAXI) Headlines

No Headlines